MD Anderson Cancer Center - Orlando — Orlando, Florida

MD Anderson Cancer Center - Orlando is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center - Orlando has participated in 4 clinical trials.

Therapeutic areas: Metastatic Renal Cell Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Novartis Pharmaceuticals, Celgene.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center - Orlando?

MD Anderson Cancer Center - Orlando has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center - Orlando conducted?

MD Anderson Cancer Center - Orlando has 4 clinical trials on record. Their work covers Metastatic Renal Cell Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer.

Is MD Anderson Cancer Center - Orlando accredited by Crixeo Health?

MD Anderson Cancer Center - Orlando has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center - Orlando?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.